Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Hematology

Why Do Blood Tests Miss Glanzmann Thrombasthenia?

At a Glance

Routine blood tests miss Glanzmann Thrombasthenia because they only count the total number of platelets, which is normal in GT. To diagnose this condition, doctors must order specialized tests like LTA or flow cytometry to evaluate if your platelets actually clump properly to stop bleeding.

It is incredibly frustrating to experience frequent, severe bleeding only to be told your blood test results are completely “normal.” This happens in Glanzmann Thrombasthenia (GT) because routine blood tests, like a Complete Blood Count (CBC), only count the number of platelets you have, rather than checking how well those platelets actually work [1]. In GT, your body produces the correct number of platelets, but they are missing a crucial protein that allows them to stick together to stop bleeding [1][2]. To catch GT, doctors must run specialized tests that measure platelet function, not just quantity.

Quantitative vs. Qualitative Blood Disorders

To understand why standard tests miss GT, it helps to know the difference between the two main types of platelet problems:

  • Quantitative disorders mean you do not have enough platelets. A routine blood test can easily spot this because the total platelet count is abnormally low [3][4].
  • Qualitative disorders (like GT) mean you have plenty of platelets, but they do not function properly [3][5]. Because the sheer number of platelets is perfectly normal, routine tests will not flag a problem [1][6].

Why the CBC and Coagulation Panels Look Normal

When you go to the doctor for unexplained bleeding, they typically run two types of initial tests. Both will look completely normal in someone with GT:

  • Complete Blood Count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in your blood. Since GT does not affect platelet production, your platelet count will almost always fall within the normal range [1][6].
  • Coagulation Profiles (PT and aPTT): These tests measure how long it takes your blood to clot by checking the “clotting factors” (proteins in the liquid part of your blood, called plasma). Because GT is a problem with the platelets themselves and not these plasma proteins, your PT and aPTT results will be normal [7][8].

The Specialized Tests Needed to Diagnose GT

Because standard tests only count your platelets, a doctor or hematologist (blood specialist) must order specialized tests to see if your platelets are actually doing their job. Note: Before taking platelet function tests, you must ask your doctor about stopping certain medications, like ibuprofen (NSAIDs), as they can artificially affect how your platelets work and skew the results.

  • Light Transmission Aggregometry (LTA): Often considered the gold standard for diagnosing GT, this test measures how well your platelets clump together (aggregate) [9][10]. In GT, LTA shows that platelets fail to clump together when exposed to most chemicals that trigger clotting. However, they will still clump in response to one specific chemical called ristocetin—seeing this specific pattern helps doctors confirm it is GT [10]. LTA usually requires freshly drawn blood tested on-site, meaning you will likely need to go to a specialized coagulation lab or hospital rather than a standard commercial lab facility.
  • Flow Cytometry: This test uses a laser to look at the surface of your platelets and measure specific proteins [11][12]. It can confirm GT by showing that your platelets are missing or have very low levels of a protein complex called glycoprotein IIb/IIIa (or αIIbβ3) [13][11].
  • Platelet Function Analyzers (like the PFA-100): This is a screening tool performed in a lab tube that mimics a bleeding blood vessel to see how long it takes for your platelets to form a plug [14]. In GT, the time it takes to close the hole is significantly longer than normal.
  • Bleeding Time Test: You might also hear about or see historical records of a “bleeding time” test. This is an older test where a small scratch is made on the arm to see how long it takes to stop bleeding, though it has largely been replaced by the PFA-100 and other modern tests.
  • Genetic Testing: Once functional tests suggest GT, your doctor will likely order a genetic test to look for mutations in the ITGA2B or ITGB3 genes [15][16]. This provides the final, definitive diagnosis.

If your bleeding symptoms don’t match your routine lab results, it is important to advocate for yourself. You can ask your doctor: “My CBC is normal but my bleeding is severe. Can we look into qualitative platelet disorders or refer me to a specialized coagulation laboratory for platelet function testing?”

Common questions in this guide

Do Glanzmann Thrombasthenia Carriers Have Bleeding Symptoms?Does Glanzmann Thrombasthenia Shorten Life Expectancy?Does Type 1 Glanzmann Thrombasthenia Mean Worse Bleeding?How Does Glanzmann Thrombasthenia Differ From HemophiliaHow Rare is Glanzmann Thrombasthenia? Prevalence & FactsHow to Stop Severe Nosebleeds with GTWill I Pass Glanzmann Thrombasthenia to My Baby?Is There a Cure for Glanzmann Thrombasthenia? ExplainedHow to Manage Heavy Periods with Glanzmann ThrombastheniaCan You Have a Baby With Glanzmann Thrombasthenia?What Sports Are Safe for Glanzmann Thrombasthenia?What to Include in a GT Emergency LetterWhy Avoid NSAIDs With Glanzmann Thrombasthenia?Why Avoid Platelet Transfusions in GT?How to Manage Dental Surgery with Glanzmann Thrombasthenia
Why does my complete blood count (CBC) look normal if I have a bleeding disorder?
A complete blood count only measures the total number of platelets in your blood. In Glanzmann Thrombasthenia, your body produces a normal amount of platelets, but they are missing a crucial protein needed to clump together and stop bleeding.
What tests are used to diagnose Glanzmann Thrombasthenia?
Doctors diagnose this condition using specialized platelet function tests. These include Light Transmission Aggregometry (LTA) and flow cytometry, which evaluate how well your platelets clump together and check for missing proteins on the platelet surface.
Should I stop taking pain relievers before a platelet function test?
Yes, certain medications like ibuprofen, aspirin, and other NSAIDs can artificially affect how your platelets work and skew the test results. Always ask your doctor which medications you need to stop taking before undergoing platelet testing.
Why do I need to go to a specialized lab for platelet testing?
Advanced tests like Light Transmission Aggregometry (LTA) usually require freshly drawn blood to accurately measure platelet function. Specialized coagulation labs or hospital facilities have the equipment necessary to test the blood on-site immediately.

Questions for Your Doctor

4 questions

  • Given my bleeding symptoms and normal CBC, can we run a Light Transmission Aggregometry (LTA) test to check my platelet function?
  • Can you refer me to a specialized coagulation laboratory or a hematologist, since functional platelet tests often require fresh blood processing?
  • Are there any specific medications, like NSAIDs or certain supplements, that I need to stop taking before I undergo platelet function testing?
  • If my functional tests suggest a platelet disorder, will we use flow cytometry or genetic testing to confirm the exact diagnosis?

Questions for You

4 questions

  • What specific bleeding symptoms (like frequent nosebleeds, heavy periods, or easy bruising) led me to seek medical care, and how long have they been happening?
  • Have I ever noticed increased bleeding after dental work or minor surgeries despite having 'normal' lab results?
  • Am I currently taking any over-the-counter pain relievers (like ibuprofen or aspirin) that might be making my bleeding worse?
  • Does anyone in my biological family have a history of unexplained bleeding or normal blood work despite bleeding issues?

References

References (16)
  1. 1

    A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia.

    Guillet B, Bayart S, Pillois X, et al.

    Journal of thrombosis and haemostasis : JTH 2019; (17(12)):2211-2215 doi:10.1111/jth.14622.

    PMID: 31565851
  2. 2

    Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.

    Bury L, Falcinelli E, Chiasserini D, et al.

    Haematologica 2016; (101(1)):46-56 doi:10.3324/haematol.2015.130849.

    PMID: 26452979
  3. 3

    Thrombotic Microangiopathies (TTP, HUS, HELLP).

    Kappler S, Ronan-Bentle S, Graham A

    Hematology/oncology clinics of North America 2017; (31(6)):1081-1103 doi:10.1016/j.hoc.2017.08.010.

    PMID: 29078925
  4. 4

    Inherited Platelet Disorders: A Short Introduction.

    Zieger B, Boeckelmann D

    Hamostaseologie 2023; (43(1)):52-59 doi:10.1055/a-1987-3310.

    PMID: 36807820
  5. 5

    Platelet disorders: an overview.

    Krishnegowda M, Rajashekaraiah V

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015; (26(5)):479-91 doi:10.1097/01.mbc.0000469521.23628.2d.

    PMID: 26126029
  6. 6

    αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.

    Morais S, Oliveira J, Lau C, et al.

    PloS one 2020; (15(12)):e0235136 doi:10.1371/journal.pone.0235136.

    PMID: 33276370
  7. 7

    Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy.

    Nurden P, Stritt S, Favier R, Nurden AT

    Haematologica 2021; (106(2)):337-350 doi:10.3324/haematol.2020.248153.

    PMID: 33147934
  8. 8

    Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.

    Samaniego EA, Gibson E, Nakagawa D, et al.

    Stroke and vascular neurology 2019; (4(1)):36-42 doi:10.1136/svn-2018-000192.

    PMID: 31105977
  9. 9

    Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction.

    Ibrahim-Kosta M, Alessi MC, Hezard N

    Hamostaseologie 2020; (40(4)):444-459 doi:10.1055/a-1223-3306.

    PMID: 32932546
  10. 10

    Strengths and Weaknesses of Light Transmission Aggregometry in Diagnosing Hereditary Platelet Function Disorders.

    Alessi MC, Sié P, Payrastre B

    Journal of clinical medicine 2020; (9(3)) doi:10.3390/jcm9030763.

    PMID: 32178287
  11. 11

    Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of thirty-two Turkish patients with Glanzmann thrombasthenia: a multicenter experience

    Saraymen B, Muhtaroğlu S, Köker MY, et al.

    Turkish journal of medical sciences 2021; (51(4)):2135-2141 doi:10.3906/sag-2006-107.

    PMID: 33957723
  12. 12

    Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.

    Zahran AM, Saad K, Elsayh KI, et al.

    Archivum immunologiae et therapiae experimentalis 2017; (65(6)):565-571 doi:10.1007/s00005-017-0454-x.

    PMID: 28161816
  13. 13

    Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.

    Ali T, Gul S, Amar A, et al.

    International journal of laboratory hematology 2020; (42(5)):628-635 doi:10.1111/ijlh.13266.

    PMID: 32558238
  14. 14

    The International Society on Thrombosis and Haemostasis Bleeding Assessment Tool's Usefulness as a Screening Questionnaire for Diagnosing and Assessing the Severity of Glanzmann Thrombasthenia in Children from Northeast Egypt.

    El-Sayed HA, Akef A, Mohammed MA, Azzam H

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2026; (42(2)):512-521 doi:10.1007/s12288-025-01994-0.

    PMID: 41728181
  15. 15

    [Molecular analysis of gene mutations in eight patients with Glanzmann's thrombasthenia].

    Miao LZ, Gan FY, Gong Y, et al.

    Zhonghua yi xue za zhi 2018; (98(30)):2418-2423 doi:10.3760/cma.j.issn.0376-2491.2018.30.010.

    PMID: 30138987
  16. 16

    Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia.

    Wang Z, Xu Y, Sun Y, et al.

    Frontiers in pediatrics 2022; (10()):1062900 doi:10.3389/fped.2022.1062900.

    PMID: 36704147

This page provides educational information about testing for Glanzmann Thrombasthenia. It is not intended to replace professional medical advice; always consult a hematologist or healthcare provider for specialized diagnostic testing.

Get notified when new evidence is published on Glanzmann Thrombasthenia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.